How Big Is the Injection Device Market | Segments & Insights 2031

Code: MTA6685 Publication Date: Jul 2025

How Big Is the Injection Device Market?

According to 6Wresearch internal database and industry insights, the injection device market was valued at USD 24.8 billion in 2024 and is projected to surpass USD 41.6 billion by 2031, advancing at a CAGR of 6.90%.

The increased preference for self-administration of injectable therapies and the rising demand for biologics are important factors driving the market at this time. New trends in device design focus on usability, decreased pain, and precision dosing, contributing to enhanced patient usability and acceptance of injection devices.

Growth Factors of the Injection Device Market

  • Increasing prevalence of chronic disease with increased usage of injectables
  • Advances in technology improving usability and safety of injectables
  • Growth in biologic and biosimilar medicines increasing demand for reformed delivery systems
  • Increasing home-based therapies and self-care habits
  • Regulatory embrace of smart and needle-free devices

Injection Device Market Trends

There is a significant transition in the injection device market toward connected and smart devices. The focuses of development are injection systems that have digital monitoring capabilities that can link to mobile applications to monitor dosing or send patient reminders. Demand for reusable and environmentally friendly devices is gaining traction with sustainability now being a leading issue in medical device design. Simultaneously there is growth in pharma companies co-developing customized delivery systems with the drug formulations to improve treatment plans.

Emerging Developments in the Injection Device Market

In the Injection Device Market, Wearable injectors with programmable dosing functions and real-time alerts are gaining popularity, especially for high-viscosity biologics. Companies are focusing on painless injection technologies such as microneedle patches and spring-powered needle-free systems. Manufacturing innovations, including automation and digital molding for device components, are accelerating production while reducing unit costs. Additionally, partnerships between pharmaceutical firms and device developers are leading to integrated combination products for specific therapeutic areas.

Leading Companies in the Injection Device Market

  • Becton, Dickinson and Company
  • Ypsomed Holding AG
  • Gerresheimer AG
  • Eli Lilly and Company
  • West Pharmaceutical Services
  • Nemera
  • SHL Medical

How Big Is the Injection Device Market : FAQ's

The injection device market is projected to exceed USD 41.6 billion by 2031, supported by growing use in chronic care and home-based treatments.
The injection device market features key players like BD, Ypsomed, SHL Medical, and West Pharmaceutical, all specializing in advanced delivery systems.
The injection device market is evolving with the adoption of digital tracking features, wearable formats, and sustainable, patient-friendly designs.
Innovations such as needle-free systems, microneedle technologies, and integrated drug-device combination products are transforming the injection device market.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All
Chat With 6W AI Intelligence